Novartis weighs entry into mRNA technology, chairman tells paper
ZURICH, July 1 (Reuters) - Swiss drugmaker Novartis could get into the field of messenger ribonucleic acid (mRNA) technology, which has come to the fore in...
ZURICH, July 1 (Reuters) - Swiss drugmaker Novartis could get into the field of messenger ribonucleic acid (mRNA) technology, which has come to the fore in...